Myelodysplastic/Myeloproliferative Neoplasms [clinicaltrials_resource:0bc3139433dd6f5531b29adc4deaf9fd]
clinicaltrials:NCT00002718Interleukin-2 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00002746]clinicaltrials:NCT00003593Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00004245]clinicaltrials:NCT00005622clinicaltrials:NCT00005797Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00005823]Tipifarnib in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00005846]Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00005863]Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia [clinicaltrials:NCT00006040]Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]clinicaltrials:NCT00008216Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]clinicaltrials:NCT00014495Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00019656]Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00020969]Bevacizumab in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00022048]clinicaltrials:NCT00027560clinicaltrials:NCT00028730Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00030550]Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation [clinicaltrials:NCT00036712]FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00042822]Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00043134]clinicaltrials:NCT00045305Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome [clinicaltrials:NCT00047268]VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00049686]Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00053001]Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00053157]Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer [clinicaltrials:NCT00062231]3-AP and Cytarabine in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00064090]Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00064311]Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00066300]Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy [clinicaltrials:NCT00066599]Cholecalciferol in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00068276]clinicaltrials:NCT00072475T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00080925]VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [clinicaltrials:NCT00083187]clinicaltrials:NCT00085449Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes [clinicaltrials:NCT00098683]Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00104806]
condition [clinicaltrials_vocabulary:condition]
Myelodysplastic/Myeloproliferative Neoplasms [clinicaltrials_resource:0bc3139433dd6f5531b29adc4deaf9fd]
Bio2RDF identifier
0bc3139433dd6f5531b29adc4deaf9fd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0bc3139433dd6f5531b29adc4deaf9fd
identifier
clinicaltrials_resource:0bc3139433dd6f5531b29adc4deaf9fd
title
Myelodysplastic/Myeloproliferative Neoplasms
@en
label
Myelodysplastic/Myeloprolifera ...... 3139433dd6f5531b29adc4deaf9fd]
@en